Na Liu

ORCID: 0000-0002-2493-2334
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neurosurgical Procedures and Complications
  • Neurological and metabolic disorders
  • Acute Ischemic Stroke Management
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Child Nutrition and Feeding Issues
  • Nutrition and Health in Aging
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Cerebrovascular and Carotid Artery Diseases
  • Clinical Nutrition and Gastroenterology

Southern Medical University
2022-2025

Nanfang Hospital
2022-2025

Capital Medical University
2025

Intracerebral hemorrhage (ICH) is the most lethal and devastating subtype of stroke. Basal ganglia thalamic are common types ICH, accounting for 50-70% all ICH cases, leading to disability death, it involves posterior limb internal capsule varying degrees. In this study, we investigated impact degrees involvement on prognosis patients with basal assessed whether improves predictive accuracy max-ICH score, an existing scale functional outcome. This a multicenter, retrospective, observational...

10.3389/fneur.2024.1475444 article EN cc-by Frontiers in Neurology 2025-01-07

We previously found that neurocritically ill patients are prone to refeeding syndrome (RFS), a potentially life-threatening complication. However, there is no unified or validated consensus on the screening tool for RFS so far. aimed validate and compare performance of four tools in patients. conducted single-center, observational, retrospective cohort study among adult who were admitted neurocritical care unit (NCU), received enteral nutrition 72 h longer. They scored Short Nutritional...

10.3390/nu14194032 article EN Nutrients 2022-09-28

BackgroundGlibenclamide alleviates brain edema and improves neurological outcomes in experimental models of stroke. We aimed to assess whether glibenclamide functional patients with acute ischemic stroke treated recombinant tissue plasminogen activator (rtPA).MethodsIn this randomized, double-blind, placebo-controlled trial, were recruited eight academic hospitals China. Patients eligible if they aged 18–74 years, presented a symptomatic anterior circulation occlusion deficit on the NIHSS...

10.1016/j.eclinm.2023.102305 article EN cc-by-nc-nd EClinicalMedicine 2023-11-01
Coming Soon ...